This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2019-2025.
Location History:
- New York, NY (US) (2019 - 2020)
- Philladelphia, PA (US) (2023)
Company Filing History:
Years Active: 2019-2025
Title: Christopher C Kloss: Innovator in Immunotherapy
Introduction
Christopher C Kloss is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunotherapy, holding a total of 4 patents. His work focuses on developing innovative methods and compositions that enhance the immune response against various pathologies.
Latest Patents
Among his latest patents, Kloss has developed compositions and methods for immunotherapy. These inventions provide immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells. These cells express at least one of an antigen recognizing receptor and one of a chimeric costimulatory receptor. The methods of using these immunoresponsive cells are aimed at treating neoplasia and other conditions where an increase in an antigen-specific immune response is desired.
Career Highlights
Kloss is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance his research in immunotherapy. His work has been instrumental in developing new therapeutic strategies that leverage the body's immune system to combat cancer and other diseases.
Collaborations
He collaborates with notable colleagues in the field, including Michel Sadelain and Maria Themeli. Their combined expertise contributes to the innovative research being conducted at the center.
Conclusion
Christopher C Kloss is a key figure in the advancement of immunotherapy, with a focus on enhancing immune responses through innovative cellular compositions. His contributions are paving the way for new treatment options in oncology and beyond.